Oncolytics Biotech Inc ONCY

Lengthy essay in NYT: Revolution in Cancer Treatment

[westcoast1000]

https://www.nytimes.com/2023/06/16/opinion/cancer-treatment-disparities.html?smid=url-share

This is the URL (and maybe a shared copy) of this essay today in the NYT about revolution in cancer treatement. It mentions met BC  and panc and huge needs, discusses ADCs and mentions Trodelvey. It is all over our whole area, and our indications, but does not mention us or any other drug companies. It discusses the potential for changing regimes, the lack of diversity in clinical trials etc. A valuable read.

[Noteable]

Perhaps the NYT has been reading my postings on this subject and have 'understood' what I have been saying. That would be in direct contrast to others who have an agenda here.

[fox7mf]

Yes, the NYT has been known to peruse stock discussion boards, while using as due diligence the musings of anonymous & insecure dullards. GLTA.

[Noteable]

F7mf - continues to reveal his true self

[Noteable]

And then maybe the NYT reads what others say such as David Wainer of the Wall Street Journal (WSJ) who recenty wrote that it's a "seller's market in biotech," thanks in part to the "diminishing list of desirable biotechs" and the fact that other pharma companies are in Pfizer's shoes: "About $200 billion in sales is going off patent this decade."